1. Home
  2. CHMI vs IKNA Comparison

CHMI vs IKNA Comparison

Compare CHMI & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHMI
  • IKNA
  • Stock Information
  • Founded
  • CHMI 2012
  • IKNA 2016
  • Country
  • CHMI United States
  • IKNA United States
  • Employees
  • CHMI N/A
  • IKNA N/A
  • Industry
  • CHMI Real Estate Investment Trusts
  • IKNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHMI Real Estate
  • IKNA Health Care
  • Exchange
  • CHMI Nasdaq
  • IKNA Nasdaq
  • Market Cap
  • CHMI 92.0M
  • IKNA 81.6M
  • IPO Year
  • CHMI 2013
  • IKNA 2021
  • Fundamental
  • Price
  • CHMI $3.39
  • IKNA $1.45
  • Analyst Decision
  • CHMI Buy
  • IKNA Buy
  • Analyst Count
  • CHMI 3
  • IKNA 2
  • Target Price
  • CHMI $5.00
  • IKNA $3.00
  • AVG Volume (30 Days)
  • CHMI 259.3K
  • IKNA 175.4K
  • Earning Date
  • CHMI 03-06-2025
  • IKNA 03-11-2025
  • Dividend Yield
  • CHMI 17.70%
  • IKNA N/A
  • EPS Growth
  • CHMI N/A
  • IKNA N/A
  • EPS
  • CHMI N/A
  • IKNA N/A
  • Revenue
  • CHMI N/A
  • IKNA $659,000.00
  • Revenue This Year
  • CHMI N/A
  • IKNA N/A
  • Revenue Next Year
  • CHMI $27.78
  • IKNA N/A
  • P/E Ratio
  • CHMI N/A
  • IKNA N/A
  • Revenue Growth
  • CHMI N/A
  • IKNA N/A
  • 52 Week Low
  • CHMI $2.50
  • IKNA $1.22
  • 52 Week High
  • CHMI $3.99
  • IKNA $1.94
  • Technical
  • Relative Strength Index (RSI)
  • CHMI 71.05
  • IKNA 40.55
  • Support Level
  • CHMI $3.07
  • IKNA $1.39
  • Resistance Level
  • CHMI $3.52
  • IKNA $1.53
  • Average True Range (ATR)
  • CHMI 0.09
  • IKNA 0.06
  • MACD
  • CHMI 0.03
  • IKNA -0.00
  • Stochastic Oscillator
  • CHMI 78.95
  • IKNA 37.50

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

Share on Social Networks: